Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance

International Journal of Obesity

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2bDUTFA
via IFTTT